Dr. Chenyu Lin
Overview
I am a hematologic oncologist who treats lymphoid cancers. Specifically, I see patients with conditions such as acute lymphoblastic leukemia (ALL), diffuse large B cell lymphoma (DLBCL), Burkitt lymphoma, Hodgkin's lymphoma, and mantle cell lymphoma. My specialty is in using immunotherapies such as CAR T cell therapy to treat and hopefully cure cancer. In this area, I also collaborate with other doctors in the medical oncology division to treat patients with solid tumors using cellular therapy approaches as part of clinical trials.
Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Systemic Capillary Leak Syndrome, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Stent Placement.
His clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Chronic Graft Versus Host Disease (cGvHD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Jonathan Serody is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Serody is rated as a Distinguished provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Serody is currently accepting new patients.
Duke Adult Blood And Marrow Transplant Clinic
What makes Duke Health unique in bone marrow transplants is its holistic approach. We take care of the disease -- which is important, because these are very serious, potentially fatal diseases. But at the same time, we pay attention to patients’ emotional and psychological well-being in addition to their physical well-being. And not only for patients but also the whole family, because the caregivers and other parts of the family need attention as well. I wanted to go into medicine, because it was a great way to interact and take care of patients. In my mind, cancer is one of two diseases within internal medicine where you can actually cure people. The best part of bone marrow transplant is that the time between the laboratory and the patient is short. Patients who need a transplant tend to be relatively sick and in need of new therapies. That’s been very intellectually challenging and fun. Dr. Chao is rated as a Distinguished provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft.
Duke Adult Blood And Marrow Transplant Clinic
I am a doctor and researcher who specializes in bone marrow transplants. Patients usually come to me after their cancer treatment has been unsuccessful or when their disease is high-risk and may require further care. When I first see a patient, it is important for me to hear their story, the history of their condition and their treatment goals. This information is important so we can decide, together, which treatments to pursue and to what degree. For me, it is a privilege to get to know where people come from and to help families through their difficult time. I grew up working in a restaurant, so I was exposed to serving the public at an early age. As I became educated, I decided that I wanted to help others in a different capacity, so I pursued medicine. Outside of work, I like spending time enjoying nature and the beauty of North Carolina with my children and husband. Dr. Sarantopoulos is rated as a Distinguished provider by MediFind in the treatment of Chronic Graft Versus Host Disease (cGvHD). Her top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- B-Cell LymphomaDr. Lin isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantDr. Lin isExperienced. Learn about Bone Marrow Transplant.
- Deep Vein ThrombosisDr. Lin isExperienced. Learn about Deep Vein Thrombosis.
- LeukemiaDr. Lin isExperienced. Learn about Leukemia.
- Lymphoid HyperplasiaDr. Lin isExperienced. Learn about Lymphoid Hyperplasia.